Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

Background: A systematic review and meta-analysis was conducted to assess breast cancer (BC) outcomes among patients with early-stage hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) BC, receiving adjuvant endocrine therapy. Methods: Randomized controlled tr...

Full description

Bibliographic Details
Main Authors: Elizabeth M. Salvo, Abril Oliva Ramirez, Jenilee Cueto, Ernest H. Law, Aaron Situ, Chris Cameron, Imtiaz A. Samjoo
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Breast
Subjects:
Early breast cancer
Adjuvant endocrine therapy
Recurrence risk
Recurrence-free survival
Systematic literature review
Meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621000230

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621000230

Similar Items